MELBOURNE ENT (00158) announced its annual results for the period ending September 30, 2025. The group recorded revenue of HK$164 million, representing a 1.6% year-on-year increase. However, shareholders' attributable loss expanded significantly by 309.61% to HK$640 million compared to the previous year. Basic loss per share stood at HK$25.62.